Bahl & Gaynor Inc Smith & Nephew PLC Transaction History

Bahl & Gaynor Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$32.4 - $38.6 $433,674 - $516,661	-13,385 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$35.11 - $37.52 $32,476 - $34,706	-925 Reduced 6.46%	13,385 $496,000
Q2 2018 Aug 14, 2018	SELL	$35.44 - $39.44 $542,586 - $603,826	-15,310 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$34.12 - $38.45 $511 - $576	-15 Reduced 0.1%	15,310 $584,000
Q3 2017 Nov 13, 2017	SELL	$34.99 - $37.17 $236,357 - $251,083	-6,755 Reduced 30.59%	15,325 $558,000
Q2 2017 Aug 11, 2017	BUY	N/A	640 Added 2.99%	22,080 $769,000
Q2 2017 Aug 10, 2017	BUY	N/A	21,440	21,440 $645,000

212

29.9M

900

6.6K

Ticker SNN
Exchange OTC
Sector Healthcare
Industry Medical Devices
Shares Outstandng 435,348,000
Market Cap $11B
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

Stay updated on Bahl & Gaynor Inc with notifications on news.